Global Prefilled Syringe Market Size By Type (Glass Prefilled Syringes, Polymer Prefilled Syringes), By Application (Autithrombotics, Vaccines), By Region, And Segment Forecasts, 2023 to 2032

lobal Prefilled Syringe Market Report Description

The Global Prefilled Syringe Market was valued at USD 8.9 billion in 2023 and is projected to reach USD 16.7 billion by 2031, growing at a CAGR of 8.2% during 2023-2031. The growth of this market is driven by the rising adoption of injectable biologics and biosimilars, increasing demand for patient-friendly drug delivery devices, and advancements in syringe design and materials. Prefilled syringes offer numerous benefits such as precise dosing, reduced risk of contamination, and improved convenience, making them an increasingly preferred option among healthcare professionals and patients.

The surge in chronic diseases, including diabetes, cardiovascular disorders, and autoimmune conditions, is fueling the need for self-administration of injectable therapies, further propelling the market. Moreover, pharmaceutical companies are focusing on ready-to-use delivery solutions to enhance patient compliance and reduce healthcare costs.

Drivers

✅ Rising Use of Biologics and Biosimilars

Biologics and biosimilars are increasingly used to treat chronic and complex diseases, which require precise dosing. Prefilled syringes ensure accurate administration and maintain drug stability, making them ideal for biologic formulations.

✅ Growing Preference for Self-Administration

Patients increasingly prefer home-based treatment, reducing hospital visits. Prefilled syringes, being user-friendly and safe, enable self-administration of injectable drugs, thus boosting demand.

✅ Technological Advancements in Syringe Materials

Innovations such as polymer-based syringes, silicone oil-free syringes, and needle safety systems enhance usability and reduce risks like glass breakage and contamination, driving adoption.

Restraints

❌ High Manufacturing Costs

The complex manufacturing process, need for sterilization, and integration of advanced materials increase production costs, posing a challenge for manufacturers.

❌ Regulatory Challenges

Stringent regulatory requirements for prefilled syringes, especially for combination products with drugs, create hurdles for market entry and slow approval processes.

Opportunities

💡 Rising Demand in Emerging Markets

Rapid expansion of healthcare infrastructure and increased healthcare spending in Asia-Pacific and Latin America are creating lucrative opportunities for market players.

💡 Adoption of Sustainable & Eco-Friendly Syringes

The development of recyclable and eco-friendly prefilled syringe materials aligns with the growing demand for sustainable medical devices, opening new revenue streams.

💡 Expansion in Biologic Drug Pipelines

As the pipeline of biologics and biosimilars grows, the demand for advanced delivery solutions like prefilled syringes will accelerate.

Market by System Type Insights

Glass Prefilled Syringes dominated the market in 2023 due to their strong barrier properties and compatibility with a wide range of drugs.

However, Plastic/Polymer Prefilled Syringes are expected to witness the fastest growth owing to their break-resistance, lightweight nature, and lower risk of drug interaction.

Market by End-Use Insights

Hospitals & Clinics held the largest market share in 2023, as they are the primary centers for injectable therapies.

Home Care Settings are expected to grow significantly, driven by the rising trend of self-administration for chronic disease management.

Market by Regional Insights

North America accounted for the largest share in 2023, driven by a high prevalence of chronic diseases, strong adoption of biologics, and advanced healthcare infrastructure.

Europe remains a significant market due to widespread vaccination programs and high awareness of injectable drug safety.

Asia-Pacific is expected to record the fastest growth, supported by the growing pharmaceutical manufacturing base, increasing healthcare spending, and rising adoption of self-injection devices in countries like China, India, and Japan.

Competitive Scenario

Key players in the Global Prefilled Syringe Market include Becton, Dickinson and Company (BD), Gerresheimer AG, SCHOTT AG, Terumo Corporation, West Pharmaceutical Services, Catalent Inc., Nipro Corporation, Vetter Pharma, Haselmeier, and SHL Medical.

These companies are focusing on strategic collaborations, product innovations, and capacity expansion to gain a competitive edge.

2023: BD launched a next-generation silicone oil-free prefilled syringe to improve biologic drug stability.

2024: Gerresheimer partnered with a leading biotech firm to develop polymer-based prefilled syringes for high-viscosity biologics.

2025: SCHOTT AG expanded its prefilled syringe manufacturing facility in Asia to meet growing regional demand.

Scope of Work – Global Prefilled Syringe Market

Key Market Developments

BD introduced an eco-friendly, polymer-based prefilled syringe in 2023, reducing the risk of glass breakage and ensuring drug stability.

Gerresheimer acquired a leading polymer syringe manufacturer in 2024 to expand its product portfolio.

Terumo launched a safety-engineered prefilled syringe in 2025 to enhance needlestick prevention in hospital settings.

FAQs

1) What is the current market size of the Global Prefilled Syringe Market?

The Global Prefilled Syringe Market was valued at USD 8.9 billion in 2023.

2) What is the major growth driver of the Global Prefilled Syringe Market?

The major growth drivers include the rising adoption of biologics and biosimilars, increasing demand for self-administration devices, and advancements in syringe materials and safety features.

3) Which is the largest region during the forecast period in the Global Prefilled Syringe Market?

North America is expected to remain the largest market due to strong adoption of biologics and advanced healthcare infrastructure.

4) Which segment accounted for the largest market share in the Global Prefilled Syringe Market?

The Glass Prefilled Syringes segment accounted for the largest share in 2023, although Plastic/Polymer Syringes are growing rapidly.

5) Who are the key market players in the Global Prefilled Syringe Market?

Key players include Becton Dickinson (BD), Gerresheimer AG, SCHOTT AG, Terumo Corporation, West Pharmaceutical Services, Catalent Inc., and SHL Medical.

Would you like me to:

✅ Create a well-formatted PDF version of this report for professional use?

✅ Or prepare another similar report for a different topic?